申请人:Sapountzis Ioannis
公开号:US20110130401A1
公开(公告)日:2011-06-02
Compounds of general formula (1)
wherein A, B, R
1
to R
5
, R
x
m, n and p are defined as described in the specification, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and the use thereof [as] medicaments.
通式(1)中,A、B、R1至R5、Rxm、n和p的定义如规范所述,适用于治疗由过度或异常细胞增殖所特征的疾病,含有这种化合物的药物制剂和其用途作为药物。